Portfolio Update : Correction
24 Setembro 2021 - 3:52AM
Portfolio Update : Correction
The Board of OT4 VCT notes that Arecor Therapeutics plc
(Arecor), which at 31 May 2021 was 53 % of the OT4 NAV of
30.8p/share was based on an Arecor share price of £2.26 which has
now risen to £4.30 bid price as at market close on 23 September. In
isolation, each 100p change in Arecor's share price has a 7.15p
impact on the NAV of OT4 VCT.
The Board are in the process of preparing the accounts for the
half year ending 31 August 2021, which will including further
details of the valuation of the rest of the portfolio. These are
expected to be issued in October.
For further information please contact: Lucius Cary 01865
784466
This announcement contains inside information as stipulated
under the UK version of the Market Abuse Regulation No 596/2014
which is part of English Law by virtue of the European (Withdrawal)
Act 2018, as amended. Upon the publication of this announcement via
a Regulatory Information Service, this information is now
considered to be in the public domain.
Oxford Technology 4 Vent... (LSE:OXF)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Oxford Technology 4 Vent... (LSE:OXF)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
Notícias em tempo-real sobre Oxford Technology 4 Venture Capital Trust Plc da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de